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October 20101120 AbstractsTable II. Patency of popliteal and tibial CTO
Popliteal No. 6 mo 12 mo 18 mo 24 mo
Primary patency
PTA 32 85.9  6.6 58.4  10.3 52.6  10.8 52.6  10.8
Atherectomy 35 67.8  8.5 64.0  8.8 56.0  9.4 51.3  9.7
P .122 .944 .867 .736
Primary assisted patency
PTA 32 89.5  6.6 70.6  9.6 64.8  10.4 64.8  10.4
Atherectomy 35 80.4  7.3 72.7  8.4 64.1  9.3 64.1  9.3
P .379 .925 .810 .810
Secondary patency
PTA 32 89.5  5.8 75.2  9.6 69.4  10.0 69.4  10.0
Atherectomy 35 90.7  5.1 87.1  6.1 78.8  7.8 78.8  7.8
P .896 .389 .524 .524
Tibial
Primary patency
PTA 96 66.9  5.3 60.8  5.6 51.1  6.2 51.1  6.2
Atherectomy 121 66.4  4.6 56.4  5.0 54.8  5.1 50.2  5.6
P .992 .686 .928 .916
Primary assisted patency
PTA 96 68.1  5.3 63.6  5.5 53.9  6.1 53.9  6.1
Atherectomy 121 73.0  4.3 64.1  4.8 64.1  4.8 61.9  5.1
P .436 .751 .326 .380
Secondary patency
PTA 96 67.8  5.3 66.3  5.4 56.2  6.2 56.2  6.2
Atherectomy 121 80.6  3.8 71.5  4.6 68.4  4.9 66.5  5.1
P .059 .296 .134 .165
Table III. Patency of multilevel CTOs
Patency No. 6 mo 12 mo 18 mo 24 mo
Primary patency
PTA  stent 111 72.6  4.5 49.9  5.7 34.7  6.0 26.1  5.9
PTA 29 67.4  10.4 45.0  11.5 28.1  10.5 22.5  9.8
Ath 71 56.8  6.1 35.7  6.0 28.0  5.8 17.6  5.2
P (PTAS vs PTA) .955 .873 .726 .798
P (PTAS vs Ath) .091 .105 .214 .177
P (PTA vs Ath) .412 .440 .724 .586
Primary assistant patency
PTA  stent 111 77.9  4.2 67.9  5.1 58.0  6.0 53.6  6.3
PTA 29 77.0  9.2 49.5  11.5 44.0  11.5 38.5  11.3
Ath 71 67.4  5.7 50.7  6.3 43.0  6.4 34.8  6.4
P (PTAS vs PTA) .811 .361 .461 .422
P (PTAS vs Ath) .221 .080 .103 .065
P (PTA vs Ath) .399 .875 .808 .720
Secondary patency
PTA  stent 111 81.7  3.9 76.1  4.6 70.0  5.4 67.6  5.7
PTA 29 86.6  7.3 68.7  10.9 61.8  11.8 61.8  11.8
Ath 71 80.6  4.9 67.0  6.0 63.1  6.2 56.7  6.6
P (PTAS vs PTA) .474 .910 .865 .946
P (PTAS vs Ath) .940 .477 .587 .435
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Introduction and objectives: Infrainguinal bypass surgery (BPG) is
accompanied by significant 30-day mortality and morbidity, including early
graft failure. The goal of this study was to identify patient-specific and
procedure-specific factors that predict the rate of early graft failure in
contemporary practice.
Methods: Data were obtained from the private sector NSQIP, a
prospective, validated database collected between 2005 and 2008 from
211 hospitals, using primary and modifier CPT codes for BPG. The
primary end point was graft failure at 30 days. Procedural parameters,
patient demographics, and clinical variables were analyzed by univariate
and multivariate methods.Results: There were 9217 BPG procedures (limb salvage, 49%; infrap-
opliteal distal anastomosis, 43%; prosthetic 32%) with the following patient
variables: age, 67  12 years; male, 64%; diabetes, 44%; and dialysis, 7.4%.
Mortality was 2.4%, major morbidity was 17.3%, and graft failure rate was
6.3% at 30 days. Multivariate predictors of graft failure demonstrated corre-
lation with female gender (OR, 1.29; P  .0054), limb salvage indication
(OR, 1.60; P  .0001), infrapopliteal anastomosis (OR, 2.15; P  .0001),
composite graft (OR, 1.82; P  .0436), current smoking (OR, 1.36; P 
.0007), impaired sensorium (OR, 2.13; P  .0075), emergency procedure
(OR, 2.03; P .0001), previous vascular procedure (OR, 1.39; P .0005),
and platelets 400 K (OR, 1.49; P  .0019). High-risk composite con-
structs utilizing these significant predictive factors can identify cohorts of
patients with up to a 98-fold increase in odds of early graft failure.
Conclusions:These results describe common risk factors that correlate
with early graft thrombosis, including the unique description of its associa-
tion with thrombocytosis. Additional risk factors thus identify a subset of
patients who may benefit from adjunctive perioperative therapies.
